These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20138582)

  • 1. Anticancer genes: inducers of tumour-specific cell death signalling.
    Grimm S; Noteborn M
    Trends Mol Med; 2010 Feb; 16(2):88-96. PubMed ID: 20138582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy: an adaptable modifier of tumourigenesis.
    Wilkinson S; Ryan KM
    Curr Opin Genet Dev; 2010 Feb; 20(1):57-64. PubMed ID: 20080398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy and apoptosis: where do they meet?
    Mukhopadhyay S; Panda PK; Sinha N; Das DN; Bhutia SK
    Apoptosis; 2014 Apr; 19(4):555-66. PubMed ID: 24415198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducers of immunogenic cancer cell death.
    Dudek AM; Garg AD; Krysko DV; De Ruysscher D; Agostinis P
    Cytokine Growth Factor Rev; 2013 Aug; 24(4):319-33. PubMed ID: 23391812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life and death partners: apoptosis, autophagy and the cross-talk between them.
    Eisenberg-Lerner A; Bialik S; Simon HU; Kimchi A
    Cell Death Differ; 2009 Jul; 16(7):966-75. PubMed ID: 19325568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 Superfamily proteins in marine bivalve cancer and stress biology.
    Walker CW; Van Beneden RJ; Muttray AF; Böttger SA; Kelley ML; Tucker AE; Thomas WK
    Adv Mar Biol; 2011; 59():1-36. PubMed ID: 21724017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pdcd4 tumor suppressor: properties, functions, and their application to oncology].
    Vikhreva PN; Shepelev MV; Korobko EV; Korobko IV
    Mol Gen Mikrobiol Virusol; 2010; (2):3-11. PubMed ID: 20545042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of antisense therapy: combination with anticancer treatments.
    Biroccio A; Leonetti C; Zupi G
    Oncogene; 2003 Sep; 22(42):6579-88. PubMed ID: 14528283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elan vital, élan létal: one life but multiple deaths.
    Kroemer G; Tolkovsky AM; Zakeri Z
    Cell Death Differ; 2008 Jul; 15(7):1089-90. PubMed ID: 18552859
    [No Abstract]   [Full Text] [Related]  

  • 10. Restoration of IRF1-dependent anticancer effects by MEK inhibition in human cancer cells.
    AbuSara N; Razavi S; Derwish L; Komatsu Y; Licursi M; Hirasawa K
    Cancer Lett; 2015 Feb; 357(2):575-81. PubMed ID: 25497010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
    Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bypassing cancer drug resistance by activating multiple death pathways--a proposal from the study of circumventing cancer drug resistance by induction of necroptosis.
    Hu X; Xuan Y
    Cancer Lett; 2008 Feb; 259(2):127-37. PubMed ID: 18082322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of autophagy in cancer development and response to therapy.
    Kondo Y; Kanzawa T; Sawaya R; Kondo S
    Nat Rev Cancer; 2005 Sep; 5(9):726-34. PubMed ID: 16148885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance.
    Engelmann D; Pützer BM
    Drug Resist Updat; 2010; 13(4-5):119-31. PubMed ID: 20675184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of apoptotic pathways triggered by cytotoxic agents.
    Solary E; Plenchette S; Sordet O; Rébé C; Ducoroy P; Filomenko R; Bruey JM; Droin N; Corcos L
    Therapie; 2001; 56(5):511-8. PubMed ID: 11806287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of apoptotic or nonapoptotic cell death in determining cellular response to anticancer treatment.
    Kim R; Emi M; Tanabe K; Uchida Y; Arihiro K
    Eur J Surg Oncol; 2006 Apr; 32(3):269-77. PubMed ID: 16431074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell death in intervertebral disc degeneration.
    Ding F; Shao ZW; Xiong LM
    Apoptosis; 2013 Jul; 18(7):777-85. PubMed ID: 23512131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAIL signalling: decisions between life and death.
    Falschlehner C; Emmerich CH; Gerlach B; Walczak H
    Int J Biochem Cell Biol; 2007; 39(7-8):1462-75. PubMed ID: 17403612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy.
    de Almagro MC; Vucic D
    Exp Oncol; 2012 Oct; 34(3):200-11. PubMed ID: 23070005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The autophagic paradox in cancer therapy.
    Wu WK; Coffelt SB; Cho CH; Wang XJ; Lee CW; Chan FK; Yu J; Sung JJ
    Oncogene; 2012 Feb; 31(8):939-53. PubMed ID: 21765470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.